GlassScriptPhysician profile
Cory Pickett
NPI 1548923949
$33,592.71
in general payments reported to CMS, 2019-2025
9 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $121 · 2023: $3,150 · 2024: $17K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $32K · Food and Beverage: $1,728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $31,744.24 |
| Food and Beverage | $1,727.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $17,087.47 | 2023-2025 | Wavelight Refractive Suite, Wavelight Ex500 Excimer Laser, Centurion |
| Rxsight INC | $16,238.73 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Glaukos Corporation | $125.64 | 2025 | Photrexa Viscous and Photrexa |
| Ani Pharmaceuticals, INC. | $33.90 | 2024 | Purified Cortrophin Gel |
| Rayner Intraocular Lenses Limited | $30.81 | 2023-2024 | Omidria, Rayone Spheric, Rayone Emv |
| Harrow Eye, LLC | $23.38 | 2024 | Vevye |
| Oyster Point Pharma, INC. | $21.92 | 2025 | Ryzumvi, Tyrvaya |
| Bausch & Lomb Americas INC. | $17.07 | 2024 | Miebo |
| Biotissue Holdings INC. | $13.79 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Pickett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.